{"title":"第一个也是唯一一个获得 FDA 批准用于治疗与阿尔茨海默病相关的躁动的药物：BREXPIPPRAZOL","authors":"Doğan Dönmez","doi":"10.48176/esmj.2024.156","DOIUrl":null,"url":null,"abstract":"<jats:p xml:lang=\"tr\">-</jats:p>","PeriodicalId":348820,"journal":{"name":"Eskisehir Medical Journal, Eskisehir City Hospital","volume":"23 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"ALZHEİMER DEMANSIYLA İLİŞKİLİ AJİTASYONUN TEDAVİSİNDE FDA ONAYLI İLK ve TEK İLAÇ: BREXPİPRAZOL\",\"authors\":\"Doğan Dönmez\",\"doi\":\"10.48176/esmj.2024.156\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<jats:p xml:lang=\\\"tr\\\">-</jats:p>\",\"PeriodicalId\":348820,\"journal\":{\"name\":\"Eskisehir Medical Journal, Eskisehir City Hospital\",\"volume\":\"23 4\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Eskisehir Medical Journal, Eskisehir City Hospital\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.48176/esmj.2024.156\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eskisehir Medical Journal, Eskisehir City Hospital","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.48176/esmj.2024.156","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
